Despite recent run-ups, these two have what takes to keep rising.
News & Analysis: Kodiak Sciences Inc
KOD earnings call for the period ending March 31, 2020.
These three developmental-stage pharma stocks are attracting some of the smartest investors right now.
Seven biotechs led the way.
These stocks have soared 935% or more this year. Can they keep the momentum going?
Here's why these drugmaker stocks are the year's top performers.
Helping people stricken with illness can be richly rewarding in more ways than one.
These clinical-stage biotech stocks have delivered eye-popping gains in 2019, but what about the road ahead?
These stocks helped lead the markets higher.
Momentum continues from the drugmaker's royalty deal announced earlier this week despite a big public stock offering.